Dengue While Travelling: What to Know About Risks and Protection

Most dengue cases in travellers are mild. But a second infection with a different serotype is where the real danger lies. Here is what repeat travellers need to know.

The risk of dengue reinfection

The Americas alone recorded 13 million dengue cases and 8,200 deaths in 2024, a figure that few travellers absorb before boarding a flight to Thailand, Colombia, or Vietnam. Most people assume dengue is a rough week in bed. For first-time infections in healthy adults, that is usually true. The problem appears on the second infection.^[1]

There are four dengue serotypes: DENV-1, DENV-2, DENV-3, and DENV-4. Surviving one gives you lifelong immunity to that specific serotype only. The other three remain open targets, and a hit from a different serotype after the first can trigger a far more dangerous immune response.

Medical disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a travel medicine specialist or your healthcare provider before travelling to dengue-endemic regions. Information is accurate at time of publication but dengue outbreak status changes frequently.

How the second infection turns dangerous

The mechanism is called antibody-dependent enhancement. Antibodies from your first infection bind to the new serotype but cannot neutralise it. Instead, they help it enter more cells. The immune system overreacts, and the result can be severe dengue, a condition involving haemorrhage, plasma leakage, and in the worst cases, organ failure.^[2]

Peer-reviewed data put the relative risk of severe dengue in secondary versus primary infection at between 2 and 7 times higher. Severe dengue is still uncommon in travellers in absolute terms, but the risk is not evenly distributed. Repeat travellers to dengue-endemic destinations carry the majority of it.^[3]

This matters practically because dengue circulates in overlapping outbreak cycles. Countries such as Colombia, Vietnam, Malaysia, Sri Lanka, and Cambodia are currently flagged on the CDC global dengue travel notice. An outbreak in one country often involves a different dominant serotype from the last one you may have encountered.

What the outbreak numbers actually mean for you

Travel-associated dengue cases reported in 2024 hit 3,483 cases, an 84% increase on the prior year. That is not just higher global transmission. It reflects the fact that dengue outbreaks recur every two to five years in a given location, and more travellers are now crossing into active outbreak zones.^[1]

The CDC Yellow Book notes that Aedes aegypti, the primary dengue vector, has peak biting activity after sunrise and at sunset. That is the window when most travellers are out at markets, on day tours, or sitting on a terrace at dusk. The mosquito is adapted to your schedule.^[4]

Dengue also has no specific antiviral treatment. Management is supportive: rest, fluids, and paracetamol. Aspirin and ibuprofen are actively harmful in suspected dengue because of bleeding risk. If you are in a country with limited hospital capacity, a severe case is genuinely life-threatening.

Protection that actually works

Repellent compliance is the single highest-leverage action a traveller can take. The CDC recommends EPA-registered repellents, long-sleeved clothing, and air-conditioned or screened sleeping quarters. DEET, picaridin, and IR3535 all have strong efficacy evidence against Aedes mosquitoes.^[5]

The gap between knowing this and doing it is wide. Repellent applied once in the morning and forgotten by lunchtime offers minimal protection through the second Aedes biting peak at dusk. Reapplication on schedule, particularly after sweating in tropical heat, is the part most travellers skip.

Permethrin-treated clothing is worth considering for longer trips. It binds to fabric fibres and provides protection through multiple wash cycles, covering the skin that repellent spray misses. It is available pre-treated or as a spray for clothing treatment before departure. Our mosquito protection guide for travellers explains this multi-layered defence in detail.

The dengue vaccine question

Qdenga (TAK-003, Takeda) is the dengue vaccine most relevant for travellers. It received European Medicines Agency (EMA) authorisation in November 2022 and WHO prequalification in May 2024. A two-dose schedule three months apart offers 61% protection against confirmed dengue and 84% protection against dengue requiring hospitalisation over 4.5 years.^[6]

The eligibility question is not simple. Qdenga is recommended by the JCVI in the UK only for individuals with a prior confirmed dengue infection. The Swiss ECTM and Denmark's SSI have reached similar positions. The concern for dengue-naive travellers is that Qdenga confers weak or uncertain protection against DENV-3 and DENV-4, the two serotypes least represented in the vaccine trials, which could theoretically prime a more severe response on natural infection.^[7]

The WHO recommends that travellers with a prior confirmed dengue infection may benefit from Qdenga vaccination before travelling again to endemic areas. If you have had a laboratory-confirmed dengue infection in the past, speak to a travel medicine specialist at least three months before your departure date. The two doses must be completed before you leave.^[8]

Dengvaxia (Sanofi Pasteur), the earlier vaccine, is being withdrawn from the market and is not appropriate for travellers.

After you return: the three-week window

The CDC advises travellers to prevent mosquito bites for three weeks after returning from a dengue-risk area. The reason is viraemia: if you were bitten and infected but are still in the incubation period, a local Aedes mosquito that bites you can pick up the virus and start a local transmission chain. This is how dengue has seeded new clusters in Florida and California in recent years.^[5]

Fever, severe headache, pain behind the eyes, and joint pain appearing within two weeks of return are dengue red flags. See a doctor promptly and tell them where you have been. Do not self-medicate with aspirin or ibuprofen.

Checking outbreak status before you fly

Dengue outbreak status changes frequently. The CDC Global Dengue Travel Health Notice is updated regularly and lists countries with above-normal transmission. As of mid-2026, Colombia, Vietnam, Malaysia, Cambodia, Sri Lanka, Bolivia, and Kenya are among those flagged. Check this notice alongside a travel health advisory from your own country's public health authority at least four to six weeks before departure.

If you have had dengue before and are heading to an endemic region again, book a travel clinic appointment at least three months before you leave. That is the minimum time needed to complete the two-dose Qdenga schedule, and you will need serological confirmation of your prior infection before a clinician can offer it.

Carrying a summary of your medical history, including any prior dengue diagnosis and the serotype if you know it, is genuinely useful here. Your Nomedic International Patient Summary lets you store that information in a format any clinician can access, which removes the guesswork from pre-travel consultations.

Frequently asked questions

Can I get dengue twice?

Yes. There are four distinct dengue serotypes (DENV-1, DENV-2, DENV-3, DENV-4). A first infection gives lifelong immunity to that specific serotype but only brief cross-protection against the others. A second infection with a different serotype carries a measurably higher risk of severe dengue, with research estimating the relative risk at two to seven times that of a primary infection. Repeat travellers to endemic destinations such as Thailand, Vietnam, Indonesia, and Colombia face this risk most directly.

Is the dengue vaccine available for travellers?

Qdenga (TAK-003, Takeda) is the dengue vaccine currently authorised for travellers. It is approved by the European Medicines Agency and available in Germany, the UK, Switzerland, and several other countries, among others. Most travel medicine authorities, including the UK JCVI and Switzerland's ECTM, currently recommend it only for travellers who have had a prior confirmed dengue infection, due to uncertainty about its protection against DENV-3 and DENV-4 in dengue-naive individuals. Book a travel clinic appointment at least three months before departure, as the two-dose course requires a 3-month interval.

Is dengue fever dangerous for travellers, or just a bad flu?

For first-time infections in otherwise healthy adults, most dengue cases resolve within one to two weeks with rest and paracetamol. Severe dengue, which involves haemorrhage, dangerous drops in blood pressure, or organ involvement, is uncommon but not rare in travellers. It is significantly more likely in secondary infections. Out of over 7,500 probable travel-associated dengue cases reported in the United States between 2010 and 2021, 88 were classified as severe (about 1.1%) and 19 were fatal. Having good travel insurance with emergency medical and repatriation cover is essential.

Which countries currently have dengue outbreaks in 2026?

The CDC Global Dengue Travel Health Notice is updated regularly and as of mid-2026 flags Colombia, Vietnam, Malaysia, Cambodia, Sri Lanka, Kenya, Bolivia, Samoa, and Tonga, among others. Outbreak status changes frequently as transmission cycles shift, so always check the CDC notice directly at cdc.gov and your own country's national travel health advisory before departure. The risk is year-round in many tropical destinations and does not follow a single predictable calendar.

What time of day do dengue mosquitoes bite?

Aedes aegypti, the primary dengue vector, bites mainly during the day, with peak activity shortly after sunrise and in the late afternoon around sunset. This is different from the overnight pattern associated with malaria mosquitoes. Repellent applied only at night provides almost no dengue protection. You need to apply and reapply throughout the day, especially after swimming or sweating.

Do I need to take precautions against dengue after I get home?

Yes. The CDC recommends avoiding mosquito bites for three weeks after returning from a dengue-risk destination. If you were infected but are still in the incubation period, a local Aedes mosquito could bite you and pick up the virus, potentially starting a local transmission chain. If you develop fever, severe headache, eye pain, or joint pain within two weeks of return, see a doctor immediately and mention your travel history.